1. Home
  2. BDSX vs ARL Comparison

BDSX vs ARL Comparison

Compare BDSX & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • ARL
  • Stock Information
  • Founded
  • BDSX 2005
  • ARL 1999
  • Country
  • BDSX United States
  • ARL United States
  • Employees
  • BDSX N/A
  • ARL N/A
  • Industry
  • BDSX Precision Instruments
  • ARL Building operators
  • Sector
  • BDSX Health Care
  • ARL Real Estate
  • Exchange
  • BDSX Nasdaq
  • ARL Nasdaq
  • Market Cap
  • BDSX 115.4M
  • ARL 233.2M
  • IPO Year
  • BDSX 2020
  • ARL N/A
  • Fundamental
  • Price
  • BDSX $0.31
  • ARL $14.15
  • Analyst Decision
  • BDSX Strong Buy
  • ARL
  • Analyst Count
  • BDSX 5
  • ARL 0
  • Target Price
  • BDSX $1.75
  • ARL N/A
  • AVG Volume (30 Days)
  • BDSX 965.5K
  • ARL 3.8K
  • Earning Date
  • BDSX 08-06-2025
  • ARL 08-07-2025
  • Dividend Yield
  • BDSX N/A
  • ARL N/A
  • EPS Growth
  • BDSX N/A
  • ARL N/A
  • EPS
  • BDSX N/A
  • ARL N/A
  • Revenue
  • BDSX $74,463,000.00
  • ARL $48,234,000.00
  • Revenue This Year
  • BDSX $17.29
  • ARL N/A
  • Revenue Next Year
  • BDSX $29.33
  • ARL N/A
  • P/E Ratio
  • BDSX N/A
  • ARL N/A
  • Revenue Growth
  • BDSX 35.76
  • ARL N/A
  • 52 Week Low
  • BDSX $0.17
  • ARL $9.43
  • 52 Week High
  • BDSX $2.04
  • ARL $22.77
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 51.00
  • ARL 48.78
  • Support Level
  • BDSX $0.29
  • ARL $13.96
  • Resistance Level
  • BDSX $0.32
  • ARL $15.15
  • Average True Range (ATR)
  • BDSX 0.02
  • ARL 0.62
  • MACD
  • BDSX 0.01
  • ARL -0.07
  • Stochastic Oscillator
  • BDSX 80.29
  • ARL 37.35

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

Share on Social Networks: